Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Nivolumab 3Cyclophosphamide 3pembrolizumab 2fludarabine phosphate 2durvalumab 2Specimen Handling 2Polymerase Chain Reaction 2Leucovorin 2Interleukin-2 2Imatinib Mesylate 2Gemcitabine 2Fluorouracil 2Doxorubicin 2Dasatinib 2Capecitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2venetoclax 1vactosertib 1trametinib 1tazemetostat 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1palbociclib 1olaparib 1neratinib 1motexafin gadolinium 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × fialuridine × Gastrointestinal × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡